期刊文献+

2010—2014年解放军三一六医院念珠菌的分布及耐药性分析 被引量:2

Analysis on distribution and drug resistance of Candida sp. in 316 Hospital of PLA from 2010 to 2014
原文传递
导出
摘要 目的分析2010—2014年解放军三一六医院念珠菌的分布及耐药性,为临床治疗念珠菌感染提供依据。方法对2010年1月—2014年12月解放军三一六医院分离出的913株念珠菌的菌种分布和耐药性进行回顾性分析。结果分离得到的913株念珠菌主要来自于内科住院患者,最常见的标本来源是痰液,构成比为89.1%;最常见的念珠菌是白色念珠菌,共分离到712株,占所有菌株的78.0%,其次是光滑念珠菌、热带念珠菌和克柔念珠菌,分别占所有菌株的10.8%、4.9%、4.5%。念珠菌感染患者中性别分布并无统计学意义,但65岁以上患者所占比例显著高于65岁以下患者所占比例(P<0.001)。药敏结果显示主要的念珠菌对5-氟胞嘧啶、两性霉素B和制霉菌素均有较高的敏感率,而对氟康唑、特比奈芬、伊曲康唑和伏立康唑的耐药率较高。结论念珠菌感染应该合理规范选用抗真菌药物,防止耐药念珠菌的出现。 Objective To analyze the distribution and drug resistance of Candida sp. in 316 Hospital of PLA from 2010 to 2014 and to provide the basis for clinical treatment. Methods The distribution and drug resistance of Candida sp. in 316 Hospital of PLA from January 2010 to December 2014 were analyzed retrospectively. Results A total of 913 strains of Candida sp. were isolated, and most of them were isolated from medical patients. Candida sp. was isolated mainly from sputum samples, and the constituent ratio was 89.2%. C. albicans(712 strains) predominated in the strains and constituted 78%. Followed by C. glabrata, C. tropicalis, and C. krusei, and accounted for 10.8%, 4.9%, and 4.5%, respectively. There was no significant difference between different genders, but significant higher incidence of candidiasis was found in adults aged ≥ 65 years old than adults aged〈 65 years old(P 〈0.001). Susceptibility test results showed that main Candida sp. was sensitive to 5-flucytosine, amphotericin B, and nystatin, and the resistance rates of Candida sp. against fluconazole, terbinafine, itraconazole, and voriconazole were relatively high. Conclusion The infection of Candida sp. should be rational and standardized treatment with antifungal drugs to prevent the emergence of drug resistance.
出处 《现代药物与临床》 CAS 2016年第3期392-395,共4页 Drugs & Clinic
关键词 念珠菌 抗真菌药物 耐药性 Candida sp. antifungal drugs drug resistance
  • 相关文献

参考文献5

二级参考文献34

  • 1Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis, 1999, 29:239-244.
  • 2Garner JS, Jarvls WR, Emori TG, et al. CDC definations for nosocomial infections. Am J Infect Control, 1988, 16: 128-140.
  • 3National Committee for Clinical and Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Pennsylvania: Wayne, NCCLS; 1997.
  • 4Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and casecontrol studies. Eur J Clin Microbiol Infect Dis, 2006, 25: 419-425.
  • 5Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States : a propensity analysis. Clin Infect Dis, 2005, 41 : 1232-1239.
  • 6Yapar N, Uysal U, Yucesoy M, et al. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses, 2006, 49: 134-138.
  • 7Bassetti M, Trecarichi EM, Righi E, et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis, 2007, 58: 325 -231.
  • 8Colombo AL, Nucci M, Park BJ, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol, 2006, 44 : 2816-2823.
  • 9Viudes A, Peman J, Canton E, et al. Candidemia at a tertiarycare hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis, 2002, 21: 767 -774.
  • 10Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients : the NEMIS prspective multicenter study. Clin Infect Dis, 2001, 33 : 177-186.

共引文献53

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部